469 related articles for article (PubMed ID: 26494964)
21. Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review.
Hernaez R
Gastroenterol Hepatol; 2012 Jan; 35(1):32-41. PubMed ID: 22093607
[TBL] [Abstract][Full Text] [Related]
22. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
Scorletti E; West AL; Bhatia L; Hoile SP; McCormick KG; Burdge GC; Lillycrop KA; Clough GF; Calder PC; Byrne CD
J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
[TBL] [Abstract][Full Text] [Related]
23. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
[TBL] [Abstract][Full Text] [Related]
24. Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis.
Xu R; Tao A; Zhang S; Deng Y; Chen G
Sci Rep; 2015 Mar; 5():9284. PubMed ID: 25791171
[TBL] [Abstract][Full Text] [Related]
25. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
Arslanow A; Stokes CS; Weber SN; Grünhage F; Lammert F; Krawczyk M
Liver Int; 2016 Mar; 36(3):418-26. PubMed ID: 26264356
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.
Liu XL; Cao HX; Fan JG
J Dig Dis; 2016 Nov; 17(11):708-715. PubMed ID: 27628945
[TBL] [Abstract][Full Text] [Related]
27. Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics.
Sookoian S; Pirola CJ
Semin Liver Dis; 2019 May; 39(2):124-140. PubMed ID: 30912099
[TBL] [Abstract][Full Text] [Related]
28. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.
Dongiovanni P; Petta S; Maglio C; Fracanzani AL; Pipitone R; Mozzi E; Motta BM; Kaminska D; Rametta R; Grimaudo S; Pelusi S; Montalcini T; Alisi A; Maggioni M; Kärjä V; Borén J; Käkelä P; Di Marco V; Xing C; Nobili V; Dallapiccola B; Craxi A; Pihlajamäki J; Fargion S; Sjöström L; Carlsson LM; Romeo S; Valenti L
Hepatology; 2015 Feb; 61(2):506-14. PubMed ID: 25251399
[TBL] [Abstract][Full Text] [Related]
29. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.
Sookoian S; Pirola CJ; Valenti L; Davidson NO
Hepatology; 2020 Jul; 72(1):330-346. PubMed ID: 32170962
[TBL] [Abstract][Full Text] [Related]
30. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
Jamialahmadi O; Mancina RM; Ciociola E; Tavaglione F; Luukkonen PK; Baselli G; Malvestiti F; Thuillier D; Raverdy V; Männistö V; Pipitone RM; Pennisi G; Prati D; Spagnuolo R; Petta S; Pihlajamäki J; Pattou F; Yki-Järvinen H; Valenti L; Romeo S
Gastroenterology; 2021 Apr; 160(5):1634-1646.e7. PubMed ID: 33347879
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants in the PNPLA3 gene are associated with nonalcoholic steatohepatitis.
Islek EE; Sazci A; Ozel MD; Aygun C
Genet Test Mol Biomarkers; 2014 Jul; 18(7):489-96. PubMed ID: 24831885
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants.
Del Ben M; Polimeni L; Brancorsini M; Di Costanzo A; D'Erasmo L; Baratta F; Loffredo L; Pastori D; Pignatelli P; Violi F; Arca M; Angelico F
Eur J Intern Med; 2014 Jul; 25(6):566-70. PubMed ID: 24947770
[TBL] [Abstract][Full Text] [Related]
33. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
Hsieh CJ; Wang PW; Hu TH
PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596
[TBL] [Abstract][Full Text] [Related]
34. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
36. TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.
Chen LZ; Xia HH; Xin YN; Lin ZH; Xuan SY
J Clin Transl Hepatol; 2015 Dec; 3(4):265-70. PubMed ID: 26807382
[TBL] [Abstract][Full Text] [Related]
37. Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD).
Del Campo JA; Gallego-Durán R; Gallego P; Grande L
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562725
[TBL] [Abstract][Full Text] [Related]
38. PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease.
Krawczyk M; Portincasa P; Lammert F
Semin Liver Dis; 2013 Nov; 33(4):369-79. PubMed ID: 24222094
[TBL] [Abstract][Full Text] [Related]
39. Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system.
Pirola CJ; Salatino A; Sookoian S
World J Gastroenterol; 2021 Jan; 27(4):305-320. PubMed ID: 33584064
[TBL] [Abstract][Full Text] [Related]
40. Genetic influences in nonalcoholic fatty liver disease.
Merriman RB; Aouizerat BE; Bass NM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S30-3. PubMed ID: 16540764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
